{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:03:16Z","timestamp":1794848596446,"version":"4.9.1"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00081\/2020"],"award-info":[{"award-number":["UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0056\/2020"],"award-info":[{"award-number":["LA\/P\/0056\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pharmthera.2023.108373","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T20:29:28Z","timestamp":1678220968000},"page":"108373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":410,"special_numbering":"C","title":["Molecular mechanisms of ferroptosis and their involvement in brain diseases"],"prefix":"10.1016","volume":"244","author":[{"given":"In\u00eas","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Benfeito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108373_bb0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","article-title":"Brain mitochondrial iron accumulates in Huntington\u2019s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically","volume":"120","author":"Agrawal","year":"2018","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuro.2014.10.002","article-title":"Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke","volume":"45","author":"Ahmad","year":"2014","journal-title":"Neurotoxicology."},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb0015","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/1352458512465135","article-title":"Increased iron accumulation occurs in the earliest stages of demyelinating disease: An ultra-high field susceptibility mapping study in Clinically Isolated Syndrome","volume":"19","author":"Al-Radaideh","year":"2013","journal-title":"Multiple Sclerosis"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","year":"2021","journal-title":"Alzheimer's & Dementia"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","article-title":"Ferroptosis inhibition: Mechanisms and opportunities","volume":"38","author":"Angeli","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jnc.13024","article-title":"Lipid peroxidation is essential for \u03b1-synuclein-induced cell death","volume":"133","author":"Angelova","year":"2015","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/nmt.15.73","article-title":"Emerging therapies in Friedreich\u2019s ataxia","volume":"6","author":"Aranca","year":"2016","journal-title":"Neurodegenerative Disease Management"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0891-5849(89)90066-X","article-title":"The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid","volume":"6","author":"Aruoma","year":"1989","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101494","article-title":"Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer\u2019s disease: Evidence of ferroptosis","volume":"32","author":"Ashraf","year":"2020","journal-title":"Redox Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","article-title":"Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis","volume":"62","author":"Ayala-Pe\u00f1a","year":"2013","journal-title":"Free Radical Biology & Medicine [Internet]."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","article-title":"Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease","volume":"73","author":"Ayton","year":"2013","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0065","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1523\/JNEUROSCI.3439-14.2015","article-title":"Parkinson\u2019s disease iron deposition caused by nitric oxide-induced loss of \u03b2-amyloid precursor protein","volume":"35","author":"Ayton","year":"2015","journal-title":"The Journal of Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0070","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0009-2797(97)00164-6","article-title":"L-S,R-buthionine sulfoximine: Historical development and clinical issues","volume":"111\u2013112","author":"Bailey","year":"1998","journal-title":"Chemico-Biological Interactions"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death and Differentiation"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","article-title":"Glutathione peroxidase 4 is associated with neuromelanin in substantia Nigra and dystrophic Axons in Putamen of Parkinson\u2019s brain","volume":"6","author":"Bellinger","year":"2011","journal-title":"Molecular Neurodegeneration"},{"issue":"7784","key":"10.1016\/j.pharmthera.2023.108373_bb0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112350","article-title":"New deferiprone derivatives as multi-functional cholinesterase inhibitors: Design, synthesis and in vitro evaluation","volume":"198","author":"Bortolami","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"17","key":"10.1016\/j.pharmthera.2023.108373_bb0100","first-page":"4682","article-title":"ras oncogenes in human cancer: A review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2022.12.086","article-title":"ACSL4 and the lipoxygenases 15\/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons","volume":"195","author":"Bouchaoui","year":"2023","journal-title":"Free Radical Biology & Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108373_bb0110","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1023\/B:NERE.0000014826.00881.c3","article-title":"Role of oxidative damage in Friedreich\u2019s ataxia","volume":"29","author":"Bradley","year":"2004","journal-title":"Neurochemical Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00726-012-1280-4","article-title":"Glutamate: A truly functional amino acid","volume":"45","author":"Brosnan","year":"2013","journal-title":"Amino Acids"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2023.108373_bb0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: A review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clinical Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/iub.577","article-title":"Exploring frataxin function","volume":"64","author":"Busi","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pneurobio.2017.10.002","article-title":"Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): A master gatekeeper in CNS injury and repair","volume":"163\u2013164","author":"Cai","year":"2018","journal-title":"Progress in Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/mp.2016.196","article-title":"Glutathione peroxidase 4: A new player in neurodegeneration?","volume":"22","author":"Cardoso","year":"2017","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","article-title":"Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration","volume":"9","author":"Carlson","year":"2016","journal-title":"Redox Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0150","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1007\/s12035-018-0961-8","article-title":"Alterations in system x(c)(-) expression in the retina of type 1 diabetic rats and the role of Nrf2","volume":"55","author":"Carpi-Santos","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"9440","key":"10.1016\/j.pharmthera.2023.108373_bb0155","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420962681","article-title":"Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination","volume":"12","author":"Cheli","year":"2020","journal-title":"ASN Neuro"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0165","article-title":"Iron accumulates in Huntington\u2019s disease neurons: Protection by deferoxamine","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16043","article-title":"Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1\/Mef2 activation, leading to neurodegeneration","volume":"5","author":"Chen","year":"2016","journal-title":"Elife."},{"issue":"47","key":"10.1016\/j.pharmthera.2023.108373_bb0175","doi-asserted-by":"crossref","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","article-title":"Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis","volume":"290","author":"Chen","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0180","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3892\/or.2015.3712","article-title":"Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-\u03b3-lyase function","volume":"33","author":"Chen","year":"2015","journal-title":"Oncology Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0185","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1038\/s41598-021-92369-8","article-title":"Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice","volume":"11","author":"Chen","year":"2021","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0190","first-page":"147","article-title":"ACSL4 suppresses glioma cells proliferation via activating ferroptosis","volume":"43","author":"Cheng","year":"2020","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-2095-2_10","article-title":"A systems biology approach to iron metabolism","volume":"844","author":"Chifman","year":"2014","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pcl.2014.09.011","article-title":"Brain tumors","volume":"62","author":"Chintagumpala","year":"2015","journal-title":"Pediatric Clinics of North America"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4103\/1673-5374.266060","article-title":"Ferrostatin-1 protects HT-22 cells from oxidative toxicity","volume":"15","author":"Chu","year":"2020","journal-title":"Neural Regeneration Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0210","first-page":"228","article-title":"Alzheimer\u2019s disease: Early diagnosis and treatment","volume":"18","author":"Chu","year":"2012","journal-title":"Hong Kong Med J = Xianggang yi xue za zhi"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.118.252759","article-title":"Ferroptosis as a novel therapeutic target for Friedreich\u2019s ataxia","volume":"369","author":"Cotticelli","year":"2019","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0220","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"Cramer","year":"2017","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0225","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","article-title":"ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation","volume":"93","author":"Cui","year":"2021","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.32496","article-title":"Targeting ferroptosis in rhabdomyosarcoma cells","volume":"146","author":"D\u00e4chert","year":"2020","journal-title":"International Journal of Cancer"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108373_bb0235","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.4161\/cc.9.19.13302","article-title":"Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?","volume":"9","author":"Dang","year":"2010","journal-title":"Cell Cycle"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108373_bb0240","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","article-title":"Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy","volume":"61","author":"Devisscher","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","article-title":"Lipid peroxidation as cause of nigral cell death in Parkinson\u2019s disease","volume":"Vol. 2","author":"Dexter","year":"1986","journal-title":"Lancet (London, England). England"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0255","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","article-title":"Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer\u2019s disease mice","volume":"35","author":"Di Meco","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0260","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","article-title":"Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants","volume":"617","author":"Dinkova-Kostova","year":"2017","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0270","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0275","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife."},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb0280","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chemical Biology"},{"issue":"7681","key":"10.1016\/j.pharmthera.2023.108373_bb0285","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/d41586-017-07291-9","article-title":"The most popular genes in the human genome","volume":"551","author":"Dolgin","year":"2017","journal-title":"Nature [Internet]."},{"issue":"7784","key":"10.1016\/j.pharmthera.2023.108373_bb0290","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nature Chemical Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metabolism"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108373_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in Parkinson\u2019s disease","volume":"21","author":"Du","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","article-title":"Recent progress in ferroptosis: Inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Discovery [Internet]."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0320","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.55.11.1752","article-title":"Increased levels of plasma malondialdehyde in Friedreich ataxia","volume":"55","author":"Emond","year":"2000","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochimica et Biophysica Acta"},{"issue":"8 Suppl","key":"10.1016\/j.pharmthera.2023.108373_bb0330","first-page":"S60","article-title":"Ubiquinol: An endogenous antioxidant in aerobic organisms","volume":"71","author":"Ernster","year":"1993","journal-title":"The Clinical Investigator"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0335","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","article-title":"Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson\u2019s disease and its progression: Disease and staging biomarkers and new drug targets","volume":"617","author":"de Farias","year":"2016","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0340","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","article-title":"Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson\u2019s disease","volume":"83","author":"Faucheux","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0345","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2019.10.006","article-title":"Liproxstatin-1 protects the mouse myocardium against ischemia\/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels","volume":"520","author":"Feng","year":"2019","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0350","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1478-3231.2011.02732.x","article-title":"Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice","volume":"32","author":"Figueiredo","year":"2012","journal-title":"Liver International: Official Journal of the International Association Study Liver."},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108373_bb0355","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1073\/pnas.0702228104","article-title":"Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis","volume":"104","author":"Forte","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0360","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0365","author":"Friedreich\u2019s Ataxia - NORD (National Organization for Rare Disorders)"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0370","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death & Differentiation [Internet]"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108373_bb0375","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0380","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Molecular Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0385","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Molecular Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0390","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","article-title":"FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation","volume":"14","author":"Gaschler","year":"2018","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0395","doi-asserted-by":"crossref","first-page":"1000183","DOI":"10.3389\/fnmol.2022.1000183","article-title":"Synaptic dysfunction in ALS and FTD: Anatomical and molecular changes provide insights into mechanisms of disease","volume":"15","author":"Gelon","year":"2022","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","article-title":"\u03b1-synuclein aggregation and its modulation","volume":"100","author":"Ghosh","year":"2017","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0405","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-020-00954-y","article-title":"Iron and ferroptosis as therapeutic targets in Alzheimer\u2019s disease","volume":"18","author":"Gleason","year":"2021","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0410","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","article-title":"Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: A new action for an old drug","volume":"15","author":"Gout","year":"2001","journal-title":"Leukemia."},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108373_bb0415","doi-asserted-by":"crossref","first-page":"13704","DOI":"10.1016\/S0021-9258(18)33504-X","article-title":"Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis","volume":"257","author":"Griffith","year":"1982","journal-title":"The Journal of Biological Chemistry"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108373_bb0420","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1016\/S0021-9258(18)35980-5","article-title":"Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)","volume":"254","author":"Griffith","year":"1979","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0425","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acs.biochem.0c00030","article-title":"Ferroptosis Suppressor Protein 1 (FSP1) and Coenzyme Q(10) Cooperatively Suppress Ferroptosis","volume":"59","author":"Hadian","year":"2020","journal-title":"Biochemistry."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0430","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2020.00239","article-title":"Ferroptosis and its potential role in human diseases","author":"Han","year":"2020","journal-title":"Frontiers in Pharmacology [Internet]."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0435","first-page":"5405","article-title":"Metabolic networks in ferroptosis","volume":"15","author":"Hao","year":"2018","journal-title":"Oncology Letters"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0440","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/jnnp-2015-312665","article-title":"Tissue atrophy and elevated iron concentration in the extrapyramidal motor system in Friedreich ataxia: The IMAGE-FRDA study","volume":"87","author":"Harding","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry. England"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0445","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-4886(95)90041-1","article-title":"Direct evidence of oxidative injury produced by the Alzheimer\u2019s beta-amyloid peptide (1-40) in cultured hippocampal neurons","volume":"131","author":"Harris","year":"1995","journal-title":"Experimental Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0450","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/jmcb\/mjz007","article-title":"The long and the short of it: The MDM4 tail so far","volume":"11","author":"Haupt","year":"2019","journal-title":"Journal of Molecular Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0460","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends in Biochemical Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0465","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1871526513666131129155708","article-title":"Considerations on the mechanism of action of artemisinin antimalarials: Part 1--the \u201ccarbon radical\u201d and \u201cheme\u201d hypotheses","volume":"13","author":"Haynes","year":"2013","journal-title":"Infectious Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.821036","article-title":"The cystine\/glutamate antiporter, system x(c) (-), contributes to cortical infarction after moderate but not severe focal cerebral ischemia in mice","volume":"16","author":"He","year":"2022","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0475","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0480","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0485","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jnc.14604","article-title":"Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"148","author":"Hu","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108373_bb0490","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0495","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0510","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1523\/JNEUROSCI.5443-08.2009","article-title":"Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"29","author":"Jeong","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0515","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.biocel.2004.02.023","article-title":"Glial cells","volume":"36","author":"Jessen","year":"2004","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"48","key":"10.1016\/j.pharmthera.2023.108373_bb0520","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.1523\/JNEUROSCI.1749-20.2020","article-title":"Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination","volume":"40","author":"Jhelum","year":"2020","journal-title":"The Journal of Neuroscience"},{"issue":"7545","key":"10.1016\/j.pharmthera.2023.108373_bb0525","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0530","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nature Chemical Biology"},{"issue":"9996","key":"10.1016\/j.pharmthera.2023.108373_bb0535","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet (London, England)."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0540","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","article-title":"Temozolomide for immunomodulation in the treatment of glioblastoma","volume":"20","author":"Karachi","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0545","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/CCM.0000000000003555","article-title":"Ferroptosis contributes to neuronal death and functional outcome after traumatic brain injury","volume":"47","author":"Kenny","year":"2019","journal-title":"Critical Care Medicine"},{"issue":"9769","key":"10.1016\/j.pharmthera.2023.108373_bb0550","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet (London, England)."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010128","article-title":"Metal ion effects on A\u03b2 and Tau aggregation","volume":"19","author":"Kim","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0560","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","article-title":"Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects\u00a0: A cross-sectional study","volume":"254","author":"Klepac","year":"2007","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0565","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12311-012-0383-5","article-title":"Friedreich\u2019s ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus","volume":"11","author":"Koeppen","year":"2012","journal-title":"Cerebellum."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0570","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Central Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb0575","first-page":"1593","article-title":"Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine","volume":"47","author":"Kramer","year":"1987","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.586578","article-title":"Oxidative damage and antioxidant defense in ferroptosis","volume":"8","author":"Kuang","year":"2020","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101791","article-title":"The Nrf2 induction prevents ferroptosis in Friedreich\u2019s ataxia","volume":"38","author":"La Rosa","year":"2021","journal-title":"Redox Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0590","first-page":"6417","article-title":"Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors","volume":"34","author":"Lachaier","year":"2014","journal-title":"Anticancer Research"},{"issue":"5762","key":"10.1016\/j.pharmthera.2023.108373_bb0595","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1115035","article-title":"Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis","volume":"311","author":"Lakhani","year":"2006","journal-title":"Science."},{"issue":"s1","key":"10.1016\/j.pharmthera.2023.108373_bb0600","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.3233\/JAD-179944","article-title":"Iron and Alzheimer\u2019s disease: An update on emerging mechanisms","volume":"64","author":"Lane","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0605","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","article-title":"Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy","volume":"1861","author":"Latunde-Dada","year":"2017","journal-title":"Biochimica et Biophysica Acta - General Subjects"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0610","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nature Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0615","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","article-title":"Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington\u2019s disease mice","volume":"121","author":"Lee","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0620","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fphys.2019.00139","article-title":"Mechanisms of ferroptosis and relations with regulated cell death: A review","volume":"10","author":"Lei","year":"2019","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0625","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(-) in health and disease: From molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxidants & Redox Signaling"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0630","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death & Disease"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108373_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0098-2997(00)00006-6","article-title":"The roles of iron in health and disease","volume":"22","author":"Lieu","year":"2001","journal-title":"Molecular Aspects of Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0640","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00702-017-1695-x","article-title":"Alpha-synuclein and iron: Two keys unlocking Parkinson\u2019s disease","volume":"124","author":"Lingor","year":"2017","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0645","doi-asserted-by":"crossref","first-page":"14844","DOI":"10.1038\/ncomms14844","article-title":"Inhibiting the system x(C)(-)\/glutathione axis selectively targets cancers with mutant-p53 accumulation","volume":"8","author":"Liu","year":"2017","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0650","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0655","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: Cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108373_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218387","article-title":"The regulation of ferroptosis by tumor suppressor p53 and its pathway","volume":"21","author":"Liu","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0665","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fnins.2018.00632","article-title":"Iron and Alzheimer\u2019s disease: From pathogenesis to therapeutic implications","volume":"12","author":"Liu","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0670","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1248\/bpb.b15-00048","article-title":"The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis","volume":"38","author":"Liu","year":"2015","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0675","article-title":"Ferroptosis in low-grade glioma: A new marker for diagnosis and prognosis","volume":"26","author":"Liu","year":"2020","journal-title":"Medical Science Monitor\u202f: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0680","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2019.00075","article-title":"The role of iron in Friedreich\u2019s Ataxia: Insights from studies in human tissues and cellular and animal models","volume":"13","author":"Llorens","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0685","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12253-015-9946-3","article-title":"Ferroptosis is involved in acetaminophen induced cell death","volume":"21","author":"L\u0151rincz","year":"2015","journal-title":"Pathology Oncology Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb0690","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0695","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","article-title":"NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0700","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","article-title":"miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma","volume":"25","author":"Luo","year":"2018","journal-title":"Cell Death & Differentiation [Internet]."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0705","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer\u2019s & Dementia\u00a0: The Journal of the Alzheimer\u2019s Association"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0710","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/00207454.2017.1325883","article-title":"Neuromelanin in parkinsonian disorders: An update","volume":"127","author":"Martin-Bastida","year":"2017","journal-title":"The International Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0715","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0720","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2021.05.095","article-title":"Involvement of ferroptosis in human motor neuron cell death","volume":"566","author":"Matsuo","year":"2021","journal-title":"Biochemical and Biophysical Research Communications [Internet]."},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0730","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochimica et Biophysica Acta. Proteins and Proteomics"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0735","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.emboj.7600041","article-title":"Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis","volume":"23","author":"Meyron-Holtz","year":"2004","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0740","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12017-018-8518-6","article-title":"The emerging roles of ferroptosis in Huntington\u2019s disease","volume":"21","author":"Mi","year":"2019","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0750","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(25)29666-5","article-title":"Protective role of glutathione","volume":"187","author":"Mitchell","year":"1973","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0755","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14737175.2015.1061934","article-title":"Recent advances in targeted therapy for glioblastoma","volume":"15","author":"Mittal","year":"2015","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0760","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s004060050027","article-title":"The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections","volume":"248","author":"M\u00f6ller","year":"1998","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0765","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/ars.2017.7493","article-title":"Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis?","volume":"29","author":"Moreau","year":"2018","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.nutr.28.061807.155521","article-title":"Systemic iron homeostasis and the iron-responsive element\/iron-regulatory protein (IRE\/IRP) regulatory network","volume":"28","author":"Muckenthaler","year":"2008","journal-title":"Annual Review of Nutrition"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb0775","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: Physiological functions of the amyloid precursor protein family","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Nature Reviews Neuroscience [Internet]."},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb0780","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/0896-6273(89)90043-3","article-title":"Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress","volume":"2","author":"Murphy","year":"1989","journal-title":"Neuron."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0785","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1552-6569.2008.00296.x","article-title":"Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis","volume":"19","author":"Neema","year":"2009","journal-title":"Journal of Neuroimaging"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0790","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101502","article-title":"Role and mechanism of ferroptosis in neurological diseases","volume":"61","author":"Ou","year":"2022","journal-title":"Molecular Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0800","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.24248","article-title":"Deferiprone in Friedreich ataxia: A 6-month randomized controlled trial","volume":"76","author":"Pandolfo","year":"2014","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0805","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","article-title":"ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation","volume":"10","author":"Park","year":"2019","journal-title":"Cell Death & Disease"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108373_bb0810","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: Insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"issue":"6\u20137","key":"10.1016\/j.pharmthera.2023.108373_bb0815","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson\u2019s disease","volume":"104","author":"Pearce","year":"1997","journal-title":"Journal of Neural Transmission"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb0820","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2362.2001.00922.x","article-title":"Glutathione in blood of patients with Friedreich\u2019s ataxia","volume":"31","author":"Piemonte","year":"2001","journal-title":"European Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0825","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5114\/fn.2012.30522","article-title":"Oxidative stress--assassin behind the ischemic stroke","volume":"50","author":"Pradeep","year":"2012","journal-title":"Folia Neuropathologica"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104919","article-title":"The application of ferroptosis in diseases","volume":"159","author":"Qiu","year":"2020","journal-title":"Pharmacological Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108373_bb0835","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJM200105103441907","article-title":"Spontaneous intracerebral hemorrhage","volume":"344","author":"Qureshi","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0840","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fnmol.2018.00276","article-title":"Untangling tau and iron: Exploring the interaction between iron and tau in neurodegeneration","volume":"11","author":"Rao","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0845","first-page":"301","article-title":"NOX activation by subunit interaction and underlying mechanisms in disease","volume":"10","author":"Rastogi","year":"2016","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0850","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","article-title":"Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve","volume":"12","author":"Rayatpour","year":"2022","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb0855","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0860","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson\u2019s disease","volume":"103","author":"Reich","year":"2019","journal-title":"Medical Clinics of North America [Internet]."},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108373_bb0865","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228765","article-title":"Ferroptosis mechanisms involved in neurodegenerative diseases","volume":"21","author":"Reichert","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0870","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jmri.22590","article-title":"MRI assessment of iron deposition in multiple sclerosis","volume":"34","author":"Ropele","year":"2011","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb0875","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb0880","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","article-title":"Neuropathology of amyotrophic lateral sclerosis and its variants","volume":"33","author":"Saberi","year":"2015","journal-title":"Neurologic Clinics"},{"issue":"47","key":"10.1016\/j.pharmthera.2023.108373_bb0885","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease","volume":"105","author":"Salazar","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9423","key":"10.1016\/j.pharmthera.2023.108373_bb0890","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson\u2019s disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet (London, England)."},{"issue":"50","key":"10.1016\/j.pharmthera.2023.108373_bb0895","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.1523\/JNEUROSCI.1409-19.2019","article-title":"Iron metabolism in the peripheral nervous system: The Role of DMT1, ferritin, and transferrin receptor in Schwann Cell maturation and myelination","volume":"39","author":"Santiago Gonz\u00e1lez","year":"2019","journal-title":"The Journal of Neuroscience"},{"issue":"2702","key":"10.1016\/j.pharmthera.2023.108373_bb0900","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1126\/science.104.2702.340","article-title":"An iron-binding component in human blood plasma","volume":"104","author":"Schade","year":"1946","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0905","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/tera.1420070306","article-title":"The morphology of various types of cell death in prenatal tissues","volume":"7","author":"Schweichel","year":"1973","journal-title":"Teratology."},{"key":"10.1016\/j.pharmthera.2023.108373_bb0910","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0915","first-page":"88","article-title":"MDM2 and MDMX: Alone and together in regulation of p53","volume":"1","author":"Shadfan","year":"2012","journal-title":"Translational Cancer Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0920","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3164\/jcbn.18-25","article-title":"Modification of \u03b1-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: Its relevance to Parkinson disease","volume":"62","author":"Shamoto-Nagai","year":"2018","journal-title":"Journal of Clinical Biochemistry and Nutrition"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108373_bb0925","doi-asserted-by":"crossref","first-page":"13153","DOI":"10.1039\/C7CP00804J","article-title":"Theoretical insights into the mechanism of ferroptosis suppression via inactivation of a lipid peroxide radical by liproxstatin-1","volume":"19","author":"Sheng","year":"2017","journal-title":"Physical Chemistry Chemical Physics"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb0930","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0935","doi-asserted-by":"crossref","DOI":"10.1080\/23723556.2015.1091059","article-title":"tRNA synthase suppression activates de novo cysteine synthesis to compensate for cystine and glutathione deprivation during ferroptosis","volume":"3","author":"Shimada","year":"2016","journal-title":"Molecular & Cellular Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0940","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5535\/arm.22027","article-title":"Dementia epidemiology fact sheet 2022","volume":"46","author":"Shin","year":"2022","journal-title":"Annals of Rehabilitation Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb0945","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108373_bb0950","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0955","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"Journal of the American Chemical Society"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb0960","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u2019s disease amyloid beta peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb0965","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson\u2019s disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0970","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: A new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108373_bb0975","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X(c)(-) activity","volume":"28","author":"Song","year":"2018","journal-title":"Current Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0980","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer\u2019s disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handbook of Clinical Neurology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb0985","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103419","article-title":"Mitochondrial dysfunction in neurons in Friedreich\u2019s ataxia","volume":"102","author":"Stepanova","year":"2020","journal-title":"Molecular and Cellular Neurosciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb1000","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","article-title":"The chemistry and biology of ferroptosis","volume":"27","author":"Stockwell","year":"2020","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1010","doi-asserted-by":"crossref","first-page":"2749173","DOI":"10.1155\/2019\/2749173","article-title":"Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death","volume":"2019","author":"Sun","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb1015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb1020","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","article-title":"Activation of p62-Keap1-Nrf2 pathway protects 6-hydroxydopamine-induced ferroptosis in dopaminergic cells","volume":"57","author":"Sun","year":"2020","journal-title":"Molecular Neurobiology"},{"issue":"16","key":"10.1016\/j.pharmthera.2023.108373_bb1025","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1042\/bj1920853","article-title":"NADH- and NADPH-dependent lipid peroxidation in bovine heart submitochondrial particles. Dependence on the rate of electron flow in the respiratory chain and an antioxidant role of ubiquinol","volume":"192","author":"Takayanagi","year":"1980","journal-title":"The Biochemical Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb1035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/oxfordjournals.jbchem.a130807","article-title":"Reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation by beef heart submitochondrial particles","volume":"77","author":"Takeshige","year":"1975","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2016.06.007","article-title":"Oxidative stress and altered lipid metabolism in Friedreich ataxia","volume":"100","author":"Tamarit","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb1050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb1055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-140396","article-title":"Perturbed iron distribution in Alzheimer\u2019s disease serum, cerebrospinal fluid, and selected brain regions: A systematic review and meta-analysis","volume":"42","author":"Tao","year":"2014","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108373_bb1060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-Acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules."},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb1065","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/S0021-9258(19)39733-9","article-title":"Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides","volume":"265","author":"Tirmenstein","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108373_bb1070","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jm200605a","article-title":"Important role of oxidative stress biomarkers in Huntington\u2019s disease","volume":"54","author":"T\u00fanez","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108373_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111489","article-title":"An overview of the ferroptosis hallmarks in Friedreich\u2019s ataxia","volume":"10","author":"Turchi","year":"2020","journal-title":"Biomolecules."},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb1080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb1085","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-020-15065-7","article-title":"Analysis of DNA methylation associates the cystine\u2013glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease","volume":"11","author":"Vallerga","year":"2020","journal-title":"Nature Communications [Internet]."},{"key":"10.1016\/j.pharmthera.2023.108373_bb1090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.astrocytes.2021","article-title":"Astrocytes in amyotrophic lateral sclerosis","volume":"25","author":"Vaz","year":"2021","journal-title":"Amyotrophic Lateral Sclerosis [Internet]"},{"issue":"7664","key":"10.1016\/j.pharmthera.2023.108373_bb1095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature [Internet]."},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108373_bb1100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/5979","article-title":"Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse","volume":"21","author":"Vulpe","year":"1999","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41418-022-01089-7","article-title":"Nov). SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1","volume":"30","author":"Wang","year":"2022","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb1110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death & Differentiation [Internet]."},{"key":"10.1016\/j.pharmthera.2023.108373_bb1115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fnmol.2017.00294","article-title":"Modifications and trafficking of APP in the pathogenesis of Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2017","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb1120","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","article-title":"Development of small-molecule probes that selectively kill cells induced to express mutant RAS","volume":"22","author":"We\u00efwer","year":"2012","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1125","first-page":"7","article-title":"Current understanding of Alzheimer\u2019s disease diagnosis and treatment","author":"Weller","year":"2018","journal-title":"F1000Research."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: Biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1135","series-title":"Dementia symptoms, types, and causes","author":"White","year":"2023"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: The Fenton reaction","volume":"82\u201383","author":"Winterbourn","year":"1995","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1145","article-title":"Astrocytes express DMT1 and transferrin receptors, which transport iron thus activating Ca2+ signalling: Possible role in neuroprotection against iron overload?","author":"Xia","year":"2020","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108373_bb1150","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Reports"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2023.108373_bb1155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mad.2010.04.007","article-title":"The emerging role of iron dyshomeostasis in the mitochondrial decay of aging","volume":"131","author":"Xu","year":"2010","journal-title":"Mechanisms of Ageing and Development"},{"issue":"7146","key":"10.1016\/j.pharmthera.2023.108373_bb1160","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.pharmthera.2023.108373_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107844","article-title":"Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2\/ARE\/NF-\u03baB signal pathway","volume":"98","author":"Yan","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"34","key":"10.1016\/j.pharmthera.2023.108373_bb1175","first-page":"E4966","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108373_bb1180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chemistry & Biology"},{"issue":"7745","key":"10.1016\/j.pharmthera.2023.108373_bb1190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb1195","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Bioscience Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1200","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb1205","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03602530600971974","article-title":"Mechanistic studies of the Nrf2-Keap1 signaling pathway","volume":"38","author":"Zhang","year":"2006","journal-title":"Drug Metabolism Reviews"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108373_bb1210","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4103\/1673-5374.274344","article-title":"Neuroprotective effect of deferoxamine on erastininduced ferroptosis in primary cortical neurons","volume":"15","author":"Zhang","year":"2020","journal-title":"Neural Regeneration Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108373_bb1215","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Molecular Brain"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2018.09.012","article-title":"Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage","volume":"1701","author":"Zhang","year":"2018","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1230","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The role of erastin in ferroptosis and its prospects in cancer therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Oncotargets and Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108373_bb1235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000510083","article-title":"Ferroptosis is regulated by mitochondria in neurodegenerative diseases","volume":"20","author":"Zhou","year":"2020","journal-title":"Neurodegenerative Diseases"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108373_bb1240","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4103\/1673-5374.355822","article-title":"Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage","volume":"18","author":"Zhou","year":"2023","journal-title":"Neural Regeneration Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1245","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108373_bb1250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nature Chemical Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108373_bb1255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chembiol.2020.03.015","article-title":"Progress in understanding ferroptosis and challenges in its targeting for therapeutic benefit","volume":"27","author":"Zou","year":"2020","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108373_bb1170","article-title":"Ferroptosis: A potential therapeutic target for Alzheimer\u2019s disease","author":"Yang","year":"2022","journal-title":"Reviews in the Neurosciences"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:06:33Z","timestamp":1777493193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":246,"alternative-id":["S0163725823000372"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108373"}}